62713-961 NDC - ALLERGENA (ALLERGY RELIEF)

Drug Information

Product NDC: 62713-961

Proprietary Name: Allergena

Non Proprietary Name: Allergy Relief

Active Ingredient(s):
  • 30 [hp_X]/1 ACACIA POLLEN;
  • 30 [hp_X]/1 ACER NEGUNDO POLLEN;
  • 30 [hp_X]/1 ACER RUBRUM POLLEN;
  • 30 [hp_X]/1 ACER SACCHARUM POLLEN;
  • 30 [hp_X]/1 AGROSTIS GIGANTEA POLLEN;
  • 30 [hp_X]/1 ALNUS INCANA SUBSP. RUGOSA POLLEN;
  • 30 [hp_X]/1 ALNUS RUBRA POLLEN;
  • 30 [hp_X]/1 AMARANTHUS PALMERI POLLEN;
  • 30 [hp_X]/1 AMARANTHUS RETROFLEXUS POLLEN;
  • 30 [hp_X]/1 AMBROSIA ARTEMISIIFOLIA POLLEN;
  • 30 [hp_X]/1 AMBROSIA TRIFIDA POLLEN;
  • 30 [hp_X]/1 ARTEMISIA VULGARIS POLLEN;
  • 30 [hp_X]/1 BACCHARIS HALIMIFOLIA POLLEN;
  • 3 [hp_X]/1 BAPTISIA TINCTORIA ROOT;
  • 30 [hp_X]/1 BETULA LENTA POLLEN;
  • 30 [hp_X]/1 BETULA NIGRA POLLEN;
  • 30 [hp_X]/1 BETULA PAPYRIFERA POLLEN;
  • 30 [hp_X]/1 CARYA ALBA POLLEN;
  • 30 [hp_X]/1 CARYA GLABRA POLLEN;
  • 30 [hp_X]/1 CARYA ILLINOINENSIS POLLEN;
  • 30 [hp_X]/1 CARYA LACINIOSA POLLEN;
  • 30 [hp_X]/1 CARYA OVATA POLLEN;
  • 30 [hp_X]/1 CELTIS OCCIDENTALIS POLLEN;
  • 30 [hp_X]/1 CHENOPODIUM ALBUM POLLEN;
  • 30 [hp_X]/1 CUPRESSUS ARIZONICA POLLEN;
  • 30 [hp_X]/1 CYNODON DACTYLON POLLEN;
  • 30 [hp_X]/1 DACTYLIS GLOMERATA POLLEN;
  • 3 [hp_X]/1 ECHINACEA, UNSPECIFIED;
  • 30 [hp_X]/1 EUCALYPTUS GLOBULUS POLLEN;
  • 30 [hp_X]/1 FAGUS GRANDIFOLIA POLLEN;
  • 3 [hp_X]/1 FENUGREEK LEAF;
  • 30 [hp_X]/1 FESTUCA PRATENSIS POLLEN;
  • 30 [hp_X]/1 FRAXINUS AMERICANA POLLEN;
  • 30 [hp_X]/1 FRAXINUS PENNSYLVANICA POLLEN;
  • 30 [hp_X]/1 FRAXINUS VELUTINA POLLEN;
  • 3 [hp_X]/1 GOLDENSEAL;
  • 30 [hp_X]/1 IVA ANNUA POLLEN;
  • 30 [hp_X]/1 JUGLANS NIGRA POLLEN;
  • 30 [hp_X]/1 JUNIPERUS ASHEI POLLEN;
  • 30 [hp_X]/1 JUNIPERUS PINCHOTII POLLEN;
  • 30 [hp_X]/1 JUNIPERUS VIRGINIANA POLLEN;
  • 30 [hp_X]/1 LIGUSTRUM VULGARE POLLEN;
  • 30 [hp_X]/1 LIQUIDAMBAR STYRACIFLUA POLLEN;
  • 30 [hp_X]/1 LOLIUM PERENNE POLLEN;
  • 30 [hp_X]/1 MORELLA CERIFERA POLLEN;
  • 30 [hp_X]/1 MORUS RUBRA POLLEN;
  • 3 [hp_X]/1 MYRRH;
  • 3 [hp_X]/1 NASTURTIUM OFFICINALE;
  • 30 [hp_X]/1 PASPALUM NOTATUM POLLEN;
  • 30 [hp_X]/1 PHOENIX DACTYLIFERA POLLEN;
  • 3 [hp_X]/1 PHYTOLACCA AMERICANA ROOT;
  • 30 [hp_X]/1 PINUS STROBUS POLLEN;
  • 30 [hp_X]/1 PLANTAGO LANCEOLATA POLLEN;
  • 30 [hp_X]/1 PLATANUS OCCIDENTALIS POLLEN;
  • 30 [hp_X]/1 POA PRATENSIS POLLEN;
  • 30 [hp_X]/1 POPULUS ALBA POLLEN;
  • 30 [hp_X]/1 POPULUS DELTOIDES SUBSP. DELTOIDES POLLEN;
  • 30 [hp_X]/1 POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN;
  • 30 [hp_X]/1 POPULUS TREMULOIDES POLLEN;
  • 30 [hp_X]/1 PSEUDOTSUGA MENZIESII POLLEN;
  • 30 [hp_X]/1 QUERCUS ALBA POLLEN;
  • 30 [hp_X]/1 QUERCUS RUBRA POLLEN;
  • 30 [hp_X]/1 QUERCUS VIRGINIANA POLLEN;
  • 30 [hp_X]/1 ROBINIA PSEUDOACACIA POLLEN;
  • 30 [hp_X]/1 RUMEX CRISPUS POLLEN;
  • 30 [hp_X]/1 SALIX NIGRA POLLEN;
  • 30 [hp_X]/1 SORGHUM HALEPENSE POLLEN;
  • 30 [hp_X]/1 TAXODIUM DISTICHUM POLLEN;
  • 30 [hp_X]/1 ULMUS AMERICANA POLLEN;
  • 30 [hp_X]/1 ULMUS CRASSIFOLIA POLLEN;
  • 30 [hp_X]/1 ULMUS PUMILA POLLEN;
  • 30 [hp_X]/1 ULMUS RUBRA POLLEN;
  • 30 [hp_X]/1 URTICA DIOICA POLLEN;
  • 30 [hp_X]/1 XANTHIUM STRUMARIUM POLLEN


Administration Route(s): ORAL

Dosage Form(s): TABLET, ORALLY DISINTEGRATING

Pharmacy Class(es):
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE]

Labeler Information

Labeler Name: Meditrend, Inc. DBA Progena Professional Formulations
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:5/11/2020

Package Information

No. Package Code Package Description Billing Unit
162713-961-0190 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62713-961-01)

NDC Record

Field Name Field Value Definition
PRODUCT NDC62713-961The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEAllergenaThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
PROPRIETARY NAME SUFFIXSeasonal Allergy TabsA suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
NON PROPRIETARY NAMEAllergy ReliefThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMETABLET, ORALLY DISINTEGRATINGThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE5/11/2020This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEMeditrend, Inc. DBA Progena Professional FormulationsName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEACACIA POLLEN; ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARUM POLLEN; AGROSTIS GIGANTEA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; ALNUS RUBRA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA TRIFIDA POLLEN; ARTEMISIA VULGARIS POLLEN; BACCHARIS HALIMIFOLIA POLLEN; BAPTISIA TINCTORIA ROOT; BETULA LENTA POLLEN; BETULA NIGRA POLLEN; BETULA PAPYRIFERA POLLEN; CARYA ALBA POLLEN; CARYA GLABRA POLLEN; CARYA ILLINOINENSIS POLLEN; CARYA LACINIOSA POLLEN; CARYA OVATA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CUPRESSUS ARIZONICA POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; EUCALYPTUS GLOBULUS POLLEN; FAGUS GRANDIFOLIA POLLEN; FENUGREEK LEAF; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; IVA ANNUA POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS PINCHOTII POLLEN; JUNIPERUS VIRGINIANA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM PERENNE POLLEN; MORELLA CERIFERA POLLEN; MORUS RUBRA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PASPALUM NOTATUM POLLEN; PHOENIX DACTYLIFERA POLLEN; PHYTOLACCA AMERICANA ROOT; PINUS STROBUS POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA PRATENSIS POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES SUBSP. DELTOIDES POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS TREMULOIDES POLLEN; PSEUDOTSUGA MENZIESII POLLEN; QUERCUS ALBA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS VIRGINIANA POLLEN; ROBINIA PSEUDOACACIA POLLEN; RUMEX CRISPUS POLLEN; SALIX NIGRA POLLEN; SORGHUM HALEPENSE POLLEN; TAXODIUM DISTICHUM POLLEN; ULMUS AMERICANA POLLEN; ULMUS CRASSIFOLIA POLLEN; ULMUS PUMILA POLLEN; ULMUS RUBRA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLENAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 3; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30 
ACTIVE INGRED UNIT[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 
PHARM CLASSESAllergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023